{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52026359",
    "licUnit": "1",
    "validDate": "2029-07-30 00:00:00.000",
    "issueDate": "2014-07-30 00:00:00.000",
    "oriIssueDate": "2014-07-30",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202635908",
    "prodNameC": "捷可衛錠 5毫克",
    "prodNameE": "JAKAVI 5mg tablet",
    "indicationsName": [
        "1. 適用於治療中度風險或高風險之骨髓纖維化，包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。\r\n2. 適用於接受hydroxyurea治療後有抗藥性或無耐受性的真性紅血球增多症。\r\n3. 移植物抗宿主疾病 (GvHD)：適用於治療12 歲以上之青少年及成人，且先前曾接受皮質類固醇(corticosteroids)或其它全身性治療後反應不佳的急或慢性移植物抗宿主疾病(acute or chronic graft-versus-host disease, GvHD)病人。"
    ],
    "does": "1110",
    "packageUnit": [
        {
            "packageSpec": "一千錠以下",
            "packageUnit": "5Y"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "D9FCD98B-9BC1-4E7B-B93D-1C49198B0883",
    "subCategory": [],
    "ingredientsDesc": [
        "Ruxolitinib phosphate"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "51 免除銜接性臨床試驗"
    ],
    "applicantName": "台灣諾華股份有限公司",
    "applicantAddr": "台北市中山區民生東路三段2號8樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": "2019-07-30",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "A63B3816-C470-4B1B-A6DC-D3CD81783B5B",
            "factoryCode": "1",
            "factoryName": "NOVARTIS PHARMA STEIN AG",
            "factoryAddr": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "factoryCompanyAddr": "CH-4002,BASEL,SWITZERLAND",
            "countryCode": "CH",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCH0088000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "34564B0A-D729-4654-AF1A-5497C352DD1D",
            "factoryCode": "2",
            "factoryName": "NOVARTIS PHARMA AG",
            "factoryAddr": "LICHTSTRASSE 35 CH-4056 BASEL SWITZERLAND",
            "factoryCompanyAddr": "",
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "01",
                    "name": "許可證持有者"
                }
            ],
            "processCodeStr": "01;許可證持有者",
            "factoryKind": "M",
            "factoryNo": "FCH0088200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013004210",
            "ingredientsName": "Ruxolitinib phosphate",
            "ingredientsDesc": "Ruxolitinib phosphate",
            "concentDesc": "(eq. Ruxolitinib freebase  5MG)",
            "concent": "6.600000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EJ01"
        }
    ],
    "licBaseId": "6A18778E-2ED1-4638-8BC1-5B3C666C1910"
}